GNS Co-Founder Iya Khalil Interviewed in The Pink Sheet

At the 2017 BIO International Convention, GNS Co-Founder and Chief Commercial Officer Iya Khalil sat down with Laura Helbling, the Director of Research at Prevision Policy and a Senior Writer at Pink Sheet to discuss machine learning in drug development. The conversation focused on how GNS’ causal machine learning and simulation platform applied to massive […]

GNS Taps Nationally Regarded Epidemiologist to Put Discoveries From Causal Machine Learning and Simulation Platform in ‘Clinical Context’

Veteran Healthcare Leader Julie Slezak Appointed to Executive Vice President of Clinical Analytics CAMBRIDGE, Mass. – April 4, 2017 – Leading precision medicine company GNS Healthcare (GNS) today announced that nationally regarded epidemiologist and biostatistician Julie Slezak has been named to the newly created position Executive Vice President of Clinical Analytics. Slezak, who previously headed […]

Retrofit Partners with GNS Healthcare to Revolutionize Weight Loss

CHICAGO and CAMBRIDGE, Mass. – Sept. 28, 2015 –Retrofit,a leading provider of corporate weight management programs, and GNS Healthcare (GNS), a leading provider of analytics that drive personalized interventions to improve population health, today announced a partnership that will transform how Retrofit uses data to help clients lose weight. Retrofit uses a high-tech, high-touch approach to […]

Getting to the Essence of Value in Health Care

In this era of value-based payment, we need to consider how different players within health care approach the value equation. How would you judge the value of your health care? A longstanding definition of treatment holds that value is the health outcomes achieved for the dollars spent. Yet behind that seemingly simple formula lies much […]

How machine-learning driven interventions can build value in health care

One of the main goals of efforts to improve the quality of health care in the U.S. is to reduce variation in care, where some patients are treated optimally while others miss out on the best of medicine. This is a key driver behind the focus on population health, which in recent decades has spawned […]

GNS Healthcare Introduces MAX for Metabolic Syndrome™

Big Data-Driven Solution Is Latest in Transformative Population Health Management Suite CAMBRIDGE, Mass. – June 3, 2015 – GNS Healthcare (GNS), a leading provider of value-based analytics solutions for driving personalized interventions that improve population health, today announced the expansion of its big data-driven population health management suite of solutions with the introduction of MAX […]

Boston Business Journal: GNS Healthcare raises $10M for big data

GNS Healthcare Inc. has raised a $10 million Series B funding round led by existing investor Cambia Health Solutions, based in Portland Oregon. New investors, California’s Heritage Provider Network and Mitsui & Co also joined the round. The announcement follows the Cambridge company’s expansion to a second office in Austin, Texas, and a plan to […]